相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
Samira A. Brooks et al.
EUROPEAN UROLOGY (2014)
Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain
Ewelina Rojewska et al.
MOLECULAR PAIN (2014)
GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients
Troels K. Bergmann et al.
ACTA ONCOLOGICA (2013)
PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells
W. Chien et al.
BRITISH JOURNAL OF CANCER (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity
Jimena Druker et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
In Silico Structural and Functional Characterization of the RSUME Splice Variants
Juan Gerez et al.
PLOS ONE (2013)
Concurrent Gene Signatures for Han Chinese Breast Cancers
Chi-Cheng Huang et al.
PLOS ONE (2013)
The Molecular Biology of Renal Cell Carcinoma
Stephen M. Keefe et al.
SEMINARS IN ONCOLOGY (2013)
The updated biology of hypoxia-inducible factor
Samantha N. Greer et al.
EMBO JOURNAL (2012)
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells
B. Shan et al.
ENDOCRINE-RELATED CANCER (2012)
Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes
Nicolas Skuli et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
State of the Science: An Update on Renal Cell Carcinoma
Eric Jonasch et al.
MOLECULAR CANCER RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIFα: Identification of Potential Driver and Passenger Mutations
Markus P. Rechsteiner et al.
CANCER RESEARCH (2011)
Oxygen Sensing, Homeostasis, and Disease
David De Bels et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MECHANISMS OF DISEASE Oxygen Sensing, Homeostasis, and Disease
Gregg L. Semenza
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Recent updates in renal cell carcinoma
W. Kimryn Rathmell et al.
CURRENT OPINION IN ONCOLOGY (2010)
RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2 alpha
Martijn van Hagen et al.
NUCLEIC ACIDS RESEARCH (2010)
PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia
X. Kang et al.
ONCOGENE (2010)
Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
Qiliang Cai et al.
PLOS ONE (2010)
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells
Eva Juengel et al.
BMC CANCER (2009)
SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation
Chao Huang et al.
EMBO JOURNAL (2009)
VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL
Katja Knauth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
HIF at a glance
M. Christiane Brahimi-Horn et al.
JOURNAL OF CELL SCIENCE (2009)
VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy
C. Lance Cowey et al.
CURRENT ONCOLOGY REPORTS (2009)
Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Alan L. Schwartz et al.
Annual Review of Pharmacology and Toxicology (2008)
Transient focal cerebral ischemia induces a dramatic activation of small ubiquitin-like modifier conjugation
Wei Yang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Comprehensive spatiotemporal transcriptomic analyses of the ganglionic eminences demonstrate the uniqueness of its caudal subdivision
Susan Willi-Monnerat et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Increased protein SUMOylation following focal cerebral ischemia
Helena Cimarosti et al.
NEUROPHARMACOLOGY (2008)
VHL Type 2B Mutations Retain VBC Complex Form and Function
Kathryn E. Hacker et al.
PLOS ONE (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
Concepts in sumoylation: a decade on
Ruth Geiss-Friedlander et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
SUMO-Specific protease 1 is essential for stabilization of HIF1α during hypoxia
Jinke Cheng et al.
CELL (2007)
RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia
Alberto Carbia-Nagashima et al.
CELL (2007)
Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo
William Y. Kim et al.
EMBO JOURNAL (2006)
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity:: Assessment of an oral agent that stimulates erythropoietin production
M Safran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumor suppression by the von hippel-lindau protein requires phosphorylation of the acidic domain
MP Lolkema et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphorylation of c-fos by members of the p38 MAPK family - Role in the AP-1 response to UV light
T Tanos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
SUMO: A history of modification
RT Hay
MOLECULAR CELL (2005)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations
WK Rathmell et al.
CANCER RESEARCH (2004)
Sumoylation increases HIF-1 stability and its transcriptional activity
SH Bae et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk
M Páez-Pereda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells
CP Castro et al.
ENDOCRINOLOGY (2003)
Sequence determinants in hypoxia-inducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3
JH Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein
I Groulx et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma
JK Maranchie et al.
CANCER CELL (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells
DE Post et al.
GENE THERAPY (2001)
Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9
MH Tatham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
MA Hoffman et al.
HUMAN MOLECULAR GENETICS (2001)
SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting
MS Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products
AR Schoenfeld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
分享论文
